Potassium Iodide → HCID 131726487, compound
Reaction equation
[F:1][C:2]([F:31])([F:30])[C:3]1[CH:4]=[C:5]([CH:23]=[C:24]([C:26]([F:29])([F:28])[F:27])[CH:25]=1)[C:6]([N:8]1[CH2:13][CH2:12][NH:11][CH2:10][C@H:9]1[CH2:14][C:15]1[CH:20]=[CH:19][C:18]([CH3:21])=[C:17]([OH:22])[CH:16]=1)=[O:7].[I-].[K+].[ClH:34].[Cl:35][CH2:36][CH2:37][N:38]1[CH2:43][CH2:42][O:41][C@H:40]([CH2:44][O:45][CH3:46])[CH2:39]1.C(N(CC)C(C)C)(C)C>O.C(OCC)(=O)C.CN(C)C=O>[OH2:7].[ClH:35].[ClH:34].[F:31][C:2]([F:1])([F:30])[C:3]1[CH:4]=[C:5]([CH:23]=[C:24]([C:26]([F:27])([F:28])[F:29])[CH:25]=1)[C:6]([N:8]1[CH2:13][CH2:12][N:11]([CH2:36][CH2:37][N:38]2[CH2:43][CH2:42][O:41][C@H:40]([CH2:44][O:45][CH3:46])[CH2:39]2)[CH2:10][C@H:9]1[CH2:14][C:15]1[CH:20]=[CH:19][C:18]([CH3:21])=[C:17]([OH:22])[CH:16]=1)=[O:7].[OH2:7].[OH2:7].[F:31][C:2]([C:3]1[CH:4]=[C:5]([CH:23]=[C:24]([C:26]([F:27])([F:28])[F:29])[CH:25]=1)[C:6]([N:8]1[CH2:13][CH2:12][N:11]([CH2:36][CH2:37][N:38]2[CH2:43][CH2:42][O:41][C@H:40]([CH2:44][O:45][CH3:46])[CH2:39]2)[CH2:10][C@H:9]1[CH2:14][C:15]1[CH:20]=[CH:19][C:18]([CH3:21])=[C:17]([OH:22])[CH:16]=1)=[O:7])([F:1])[F:30].[ClH:35].[ClH:35]Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Conditions
- Temperature
- 52.5 °C
Procedure
Into N,N-dimethylformamide (33.5 ml) were charged (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-2-(3-hydroxy-4-methylbenzyl)piperazine (6.7 g), potassium iodide (8.0 g), (2S)-4-(2-chloroethyl)-2-(methoxymethyl)morpholine hydrochloride (4.3 g) and N,N-diisopropylethylamine (4.8 g). The temperature was raised to 50 to 55° C. and allowed to react for 5 hours. After the reaction was completed, the reaction solution was cooled to room temperature. Ethyl acetate (33.5 ml) and water (33.5 ml) were added and mixed. After mixing was completed, layers were separated. The organic layer was washed by adding water (33.5 ml), layers were separated and the organic layer was concentrated. Ethyl acetate (33.5 ml) was added to the obtained oil of (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-4-[2-[(2S)-2-(methoxymethyl)-morpholino]ethyl]-2-(3-hydroxy-4-methylbenzyl)piperazine to effect dissolution and then the solution was concentrated. The obtained concentrate was diluted with acetone (100 ml), clarified and filtered, and washed with acetone (34 ml). Concentrated hydrochloric acid (3.9 g) was added dropwise to the combined filtrate and washings at room temperature and crystallization was effected under ice-cooling for 8 hours. Crystals were collected by filtration, washed with acetone (33.5 ml), dried under reduced pressure and moistured to give (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-4-[2-[(2S)-2-(methoxymethyl)morpholino]ethyl]-2-(3-hydroxy-4-methyl-benzyl)piperazine dihydrochloride sesquihydrate (8.1 g, yield: 76.7%) in the form of white crystals.
Workup
- customto react for 5 hours
- temperaturethe reaction solution was cooled to room temperature
- additionmixed
- additionAfter mixing
- customlayers were separated
- washThe organic layer was washed
- additionby adding water (33.5 ml), layers
- customwere separated
- concentrationthe organic layer was concentrated
- additionEthyl acetate (33.5 ml) was added to the obtained oil of (2R)-1-[3,5-bis(trifluoromethyl)benzoyl]-4-[2-[(2S)-2-(methoxymethyl)-morpholino]ethyl]-2-(3-hydroxy-4-methylbenzyl)piperazine
- dissolutiondissolution
- concentrationthe solution was concentrated
- concentrationThe obtained concentrate
- additionwas diluted with acetone (100 ml)
- filtrationfiltered
- washwashed with acetone (34 ml)
- additionConcentrated hydrochloric acid (3.9 g) was added dropwise to the combined filtrate and washings at room temperature
- customcrystallization
- temperaturecooling for 8 hours
- filtrationCrystals were collected by filtration
- washwashed with acetone (33.5 ml)
- customdried under reduced pressure
Sources & evidence
- ORD record
- ord-c980fd092f8a44f3ad2da11fa8584d5f
- Source dataset
- uspto-grants-2007_06
- Patent number
- US07229992B2
Reaction notes
Loading…